Yahoo Finance German scientists' high hopes for 'budget' moon rover
German scientists hope to see their home-made, low-cost, robot examining the moon in the near future while they work on ways to lower risks of malfunctioning. Edward Baran reports.
German scientists hope to see their home-made, low-cost, robot examining the moon in the near future while they work on ways to lower risks of malfunctioning. Edward Baran reports.
DUBAI, United Arab Emirates, April 24, 2024--Horizon FCB Dubai Charts the Future of Advertising in Logistics with DHL’s "Delivered Yesterday" Campaign
Oklahoma authorities said Tuesday that the 10-year-old woke up on April 22 and discovered the bodies of five family members
Amersham & Chiltern Rugby Club savoured a day with British & Irish Lions and Rugby World Cup winner Jason Robinson.
First non-immunosuppressive therapy for the treatment of IgA nephropathy (IgAN) approved in Europe Conditional marketing authorization is based on statistically significant and clinically meaningful results from the Phase 3 PROTECT Study SAN DIEGO, April 24, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc., (Nasdaq: TVTX) and CSL Vifor today announced that the European Commission has granted conditional marketing authorization (CMA) for FILSPARI (sparsentan) for the treatment of adults with p
Korean Air is in talks over the purchase of at least 10 Boeing 777X jetliners in a potential tilt back towards its traditional U.S. supplier after placing a major order with European rival Airbus, two industry sources said. The discussions come weeks after Korean announced an order for 33 A350 jets from Airbus in what was widely seen as a breakthrough for the European planemaker into the flag carrier's Boeing-dominated wide-body fleet. The sources said discussions between Korean Air and Boeing on the 777X, an upgrade of the 777 mini-jumbo already used by South Korea's largest carrier, were ongoing.
"Shogun" star and producer Hiroyuki Sanada explains how his embattled Yoshii Toranaga masterfully manuevered in the acclaimed FX series' finale.
A rally attempt is underway. Tesla and AI play Vertiv were big earnings winners. Meta and ServiceNow loom tonight.
NEW YORK and VIENNA, Austria, April 24, 2024 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced that the Company has received clearance from the U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND) application for HB-700, a novel arenaviral therapeutic vaccine for the treatment of KRAS-mutated cancers. HOOKIPA’s HB-700 program is designed
I’ve previously exhibited a total lack of interest in gardening, but this is the year when everything will change
According to a recent analysis of retirement expenses on GOBankingRates, the amount of money you'll need for retirement will vary greatly depending on what state you choose to live in. It can cost you...
Enacted in 1935, Social Security has been one of the most successful programs in U.S. history. Social Security was originally designed to help provide a backstop for Americans suffering from the...
Experts believe that phone-based childhoods are seriously harming mental health — and parents are fighting back, says Emily Phillips
Paper highlights findings on impact of a gluten-containing diet on serologic status in celiac diseaseBOCA RATON, Fla., April 24, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, today announced research generated from two previously completed Phase 2 clinical trials of latiglutenase has be
Reports nine straight quarters of industry-leading growthReaffirms industry-leading 2024 financial guidance More Canadians continue to choose Rogers over any other carrier 124,000 postpaid mobile phone and retail Internet net addsPostpaid mobile phone net adds of 98,000, up 3,000Retail Internet net adds of 26,000, up 12,000 Delivers industry-leading growth in Cable and Wireless Total service revenue up 31%; adjusted EBITDA up 34%Wireless service revenue and adjusted EBITDA up 9% Wireless blended
DURHAM, N.C., April 24, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced that it will host a live conference call and audio webcast on Wednesday, May 1, 2024 at 8:30 a.m. ET to report financial results for the first quarter ended March 31, 2024, and to provide a business overview. To access the live conference call, please dial (646)
CHICAGO, April 24, 2024 (GLOBE NEWSWIRE) -- Alts Marketplace, a division of Formidium Corp, is pleased to announce significant advancements in the realm of alternative investments. Positioned as a pioneering force in this evolving landscape, Alts Marketplace continues to shape the future of investment opportunities. In a move aimed at enhancing investor experiences, Alts Marketplace has forged collaborations with esteemed partners. These partnerships enable investors to access exclusive VIP expe
BRIDGEVILLE, Pa., April 24, 2024 (GLOBE NEWSWIRE) -- Universal Stainless & Alloy Products, Inc. (Nasdaq: USAP) announced today that it will report financial results for the first quarter of 2024 on Wednesday, May 1, 2024. In conjunction with the earnings release, the Company will host a conference call at 11:00 a.m. (Eastern) on May 1st. The call will be webcast simultaneously for all interested parties. Call Dial-In Procedures: Please Click Here to register for the conference call and obtain yo
July 5, 2024 payment date following June 10, 2024 record dateTORONTO, April 24, 2024 (GLOBE NEWSWIRE) -- Rogers Communications Inc. (TSX: RCI.A and RCI.B) (NYSE: RCI) (“Rogers”) announced that its Board of Directors declared a quarterly dividend totaling 50 cents per share (the “Quarterly Dividend”) on each of its outstanding Class B Non-Voting shares (“Class B Shares”) and Class A Voting shares. The Quarterly Dividend will be paid on July 5, 2024 to shareholders of record on June 10, 2024. Quar
Following incubation with HCA Healthcare EDs, Augmedix announces the general availability of Augmedix Go in emergency departmentsSAN FRANCISCO, April 24, 2024 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, today announced the general availability of Augmedix Go for emergency departments (EDs), marking the launch of the industry’s first fully-automated, generative AI (GenAI) powered medical documentation product for EDs across the cou
PETACH TIKVA, Israel, April 24, 2024 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today announced that it will report its first quarter 2024 financial results and operational highlights before the open of the U.S. financial markets on Wednesday, May 8, 2024. The Company will host a conference call and webcast at 8:30 AM Eastern Time to discuss the results and provide an update on business operati